Sanford C. Bernstein Begins Coverage on CME Group (CME)

Sanford C. Bernstein assumed coverage on shares of CME Group (NASDAQ:CME) in a research note published on Monday, MarketBeat Ratings reports. The firm issued an outperform rating and a $190.00 price target on the financial services provider’s stock.

Several other research analysts have also recently issued reports on CME. Zacks Investment Research raised CME Group from a hold rating to a buy rating and set a $180.00 target price on the stock in a research report on Friday, April 6th. Deutsche Bank raised their target price on CME Group from $185.00 to $197.00 and gave the stock a buy rating in a research report on Friday, April 6th. ValuEngine raised CME Group from a hold rating to a buy rating in a research report on Monday, April 2nd. Barclays raised their target price on CME Group from $170.00 to $175.00 and gave the stock an overweight rating in a research report on Friday, February 2nd. Finally, Berenberg Bank assumed coverage on CME Group in a research report on Thursday, January 25th. They issued a hold rating and a $170.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of $165.57.

NASDAQ CME opened at $161.26 on Monday. CME Group has a one year low of $114.82 and a one year high of $171.71. The stock has a market capitalization of $54,182.48, a P/E ratio of 33.81, a price-to-earnings-growth ratio of 2.18 and a beta of 0.56. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.10.



CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, topping the consensus estimate of $1.10 by $0.02. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The company had revenue of $900.00 million during the quarter, compared to the consensus estimate of $886.85 million. During the same period last year, the company earned $1.14 EPS. CME Group’s revenue for the quarter was down 1.4% on a year-over-year basis. sell-side analysts expect that CME Group will post 6.96 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Friday, March 9th were given a dividend of $0.70 per share. This is a boost from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.74%. The ex-dividend date was Thursday, March 8th. CME Group’s payout ratio is presently 58.70%.

In other news, insider Derek Sammann sold 2,400 shares of CME Group stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $161.66, for a total transaction of $387,984.00. Following the transaction, the insider now directly owns 40,153 shares of the company’s stock, valued at approximately $6,491,133.98. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Chairman Terrence A. Duffy sold 20,000 shares of CME Group stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $151.66, for a total value of $3,033,200.00. Following the transaction, the chairman now directly owns 99,239 shares in the company, valued at $15,050,586.74. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 35,699 shares of company stock worth $5,532,362. Insiders own 0.45% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. ARK Investment Management LLC bought a new stake in CME Group during the 4th quarter valued at approximately $120,000. Valeo Financial Advisors LLC bought a new stake in CME Group during the 3rd quarter valued at approximately $124,000. AlphaOne Investment Services LLC bought a new stake in CME Group during the 4th quarter valued at approximately $146,000. Mosaic Family Wealth LLC bought a new stake in CME Group during the 4th quarter valued at approximately $146,000. Finally, Truewealth LLC bought a new stake in CME Group during the 4th quarter valued at approximately $157,000. 83.12% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This article was first reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://dakotafinancialnews.com/2018/04/12/sanford-c-bernstein-begins-coverage-on-cme-group-cme.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply